Methysergide dosage and administration: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Methysergide}} {{CMG}} == <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SANSERT (METHYSERGIDE MALEATE) TABLET, COATED [NOVARTIS P...")
 
mNo edit summary
 
Line 3: Line 3:
{{CMG}}
{{CMG}}


==
==Dosage and Administration==


Usual adult dose 4-8 mg daily. Tablets to be given with meals.


Note:      There must be a medication-free interval of 3-4 weeks after every 6-month course of treatment. (See WARNINGS)


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = SANSERT (METHYSERGIDE MALEATE) TABLET, COATED [NOVARTIS PHARMACEUTICALS CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3fae28ee-700e-4d4f-a040-02ef01a2aeb4 | publisher =  | date =  | accessdate = }}</ref>
No pediatric dosage has been established.
 
If, after a 3-week trial period, efficacy has not been demonstrated, longer administration of Sansert® (methysergide maleate) is unlikely to be of benefit.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = SANSERT (METHYSERGIDE MALEATE) TABLET, COATED [NOVARTIS PHARMACEUTICALS CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3fae28ee-700e-4d4f-a040-02ef01a2aeb4 | publisher =  | date =  | accessdate = }}</ref>


==References==
==References==

Latest revision as of 19:18, 7 February 2014

Methysergide
SANSERT® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Clinical Trials on Methysergide
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosage and Administration

Usual adult dose 4-8 mg daily. Tablets to be given with meals.

Note: There must be a medication-free interval of 3-4 weeks after every 6-month course of treatment. (See WARNINGS)

No pediatric dosage has been established.

If, after a 3-week trial period, efficacy has not been demonstrated, longer administration of Sansert® (methysergide maleate) is unlikely to be of benefit.[1]

References

  1. "SANSERT (METHYSERGIDE MALEATE) TABLET, COATED [NOVARTIS PHARMACEUTICALS CORPORATION]".

Adapted from the FDA Package Insert.